Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Iolanda M. Fierro"'
Proinflammatory Responses of Heme in Alveolar Macrophages: Repercussion in Lung Hemorrhagic Episodes
Autor:
Rafael L. Simões, Maria Augusta Arruda, Cláudio Canetti, Carlos H. Serezani, Iolanda M. Fierro, Christina Barja-Fidalgo
Publikováno v:
Mediators of Inflammation, Vol 2013 (2013)
Clinical and experimental observations have supported the notion that free heme released during hemorrhagic and hemolytic episodes may have a major role in lung inflammation. With alveolar macrophages (AM) being the main line of defense in lung envir
Externí odkaz:
https://doaj.org/article/1ec1bcec84304d59862b6f436db399eb
Publikováno v:
Expert opinion on therapeutic patents. 30(11)
Zika virus (ZIKV) is transmitted to humans throughout bites ofThis review identifies patent documents on repositioning for ZIKV infection treatment of already approved drugs or phases II/III investigated drugs for other diseases. Thirty-six patents w
Autor:
Natália Mesquita de-Brito, V Morandi, Ivan M. Roitt, Iolanda M. Fierro, H Cunha-Costa, Rafael L. Simões, Christina Barja-Fidalgo
Publikováno v:
International Journal of Cancer. 140:346-357
In tumor microenvironments, the macrophage population is heterogeneous, but some macrophages can acquire tumor-promoting characteristics. These tumor-associated macrophages (TAM) exhibit an M2-like profile, with deficient production of NO and ROS, ch
Autor:
Iolanda M. Fierro, Jorge de Paula Costa Ávila, Rafaela Di Sabato Guerrante, Flavia Maria Lins Mendes, Adelaide Maria de Souza Antunes
Publikováno v:
Expert Opinion on Therapeutic Patents. 26:1449-1457
Arterial hypertension affects over one billion people around the world, making the prevention and treatment of this disease vital. Despite the efforts made to develop new antihypertensive drugs, few new therapies have become available. Angiotensin-co
Publikováno v:
Expert opinion on therapeutic patents. 28(8)
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by an inflammatory process, with a global prevalence ranging from 0.3% to 1%. The overall cost of RA drugs is estimated in $20 billion worldwide and projected to grow to $36 bill
Publikováno v:
The Natural Products Journal. 7
Autor:
Iolanda M. Fierro, Maria Simone de Menezes Alencar, Bernardo Furtado Nunes, Cristina d'Urso de Souza Mendes, Flavia Maria Lins Mendes, Adelaide Maria de Souza Antunes
Publikováno v:
Pharmaceutical Patent Analyst. 3:613-623
Recently, research in the field of cancer nanotechnology has made notable progress, and, with the fast development of nanomaterials, new treatment strategies using nanoparticles are being explored that have the potential to overcome existing problems
Publikováno v:
Revista Brasileira de Farmacognosia, Vol 23, Iss 4, Pp 716-722 (2013)
Revista Brasileira de Farmacognosia, Vol 23, Iss 4, Pp 716-719 (2013)
Revista Brasileira de Farmacognosia, Vol 23, Iss 4, Pp 716-719 (2013)
Today, one of the trends of the pharmaceutical, cosmetic and food market is the development of products with components of natural origin, rationally exploiting biodiversity. Brazilian population makes secular use of medicinal plants including andiro
Autor:
Iolanda M. Fierro, Adelaide Maria de Souza Antunes, Rafaela Di Sabato Guerrante, Maria Simone de Menezes Alencar, Flávia R L Mendes
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 4, Pp 7016-7031 (2013)
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 14; Issue 4; Pages: 7016-7031
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 14; Issue 4; Pages: 7016-7031
Investment in nanotechnology is now a given constant by governments, research centers and companies in both more developed countries and emerging markets. Due to their characteristics, such as high stability, ability to enable antigen identification
Autor:
Flavia Maria Lins Mendes, Priscila Rohem dos Santos, Rafaela Di Sabato Guerrante, Iolanda M. Fierro, Adelaide Maria de Souza Antunes
Publikováno v:
Journal of Cancer Therapy. :56-64
Cancer is a leading cause of death worldwide, and is estimated to be the cause of 13.1 million deaths in 2030. Breast cancer is the second cancer in the global mortality ranking, considering both sexes. Due to the burden of breast cancer worldwide, t